APA (7th ed.) Citation

Sanganalmath, P., Lester, J., Bradshaw, A., Das, T., Esler, C., Roy, A., . . . Hatton, M. (2018). Continuous Hyperfractionated Accelerated Radiotherapy (CHART) for Non-small Cell Lung Cancer (NSCLC): 7 Years' Experience From Nine UK Centres. Clinical Oncology, 30(3), 144. https://doi.org/10.1016/j.clon.2017.12.019

Chicago Style (17th ed.) Citation

Sanganalmath, P., et al. "Continuous Hyperfractionated Accelerated Radiotherapy (CHART) for Non-small Cell Lung Cancer (NSCLC): 7 Years' Experience From Nine UK Centres." Clinical Oncology 30, no. 3 (2018): 144. https://doi.org/10.1016/j.clon.2017.12.019.

MLA (9th ed.) Citation

Sanganalmath, P., et al. "Continuous Hyperfractionated Accelerated Radiotherapy (CHART) for Non-small Cell Lung Cancer (NSCLC): 7 Years' Experience From Nine UK Centres." Clinical Oncology, vol. 30, no. 3, 2018, p. 144, https://doi.org/10.1016/j.clon.2017.12.019.